AKT1 and hepatocellular carcinoma: When combined with LY294002, apoptosis was further enhanced (apoptosis rate of 58.16%), indicating that APS suppressed hepatoma cell proliferation through dual mechanisms: activation of autophagy and inhibition of the Akt pathway.